The Fda Has Its Eye On Gray Market Lasers
The U.S. Food & Drug Administration has brought pharmaceutical giants to their knees and recently sent shudders through the mighty tobacco industry. So it comes as a surprise that as many as 150 of the nation's ophthalmologists have decided to flatly defy tough new FDA rules on eye surgery.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.